Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Multiple Comorbidities

被引：0
|
作者：
Glaspole, I. [1 ,2 ]
Bonella, F. [3 ]
Bargagli, E. [4 ]
Glassberg, M. K. [5 ]
Caro, F. [6 ]
Stansen, W. [7 ]
Quaresma, M. [8 ]
Orsatti, L. [8 ]
Bendstrup, E. [9 ]
机构：
[1] Alfred Hlth, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia
[2] Monash Univ, Dept Med, Melbourne, Vic, Australia
[3] Duisburg Essen Univ, Interstitial & Rare Lung Dis Unit, Ruhrlandklin, Univ Hosp, Essen, Germany
[4] Siena Univ Hosp, Sect Resp Dis & Lung Transplantat, Dept Clin Med & Neurosci, Siena, Italy
[5] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[6] Maria Ferrer Hosp, Buenos Aires, DF, Argentina
[7] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
[8] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[9] Aarhus Univ Hosp, Dept Resp Dis & Allergy, Aarhus, Denmark
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4549
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities
    Ian Glaspole
    Francesco Bonella
    Elena Bargagli
    Marilyn K. Glassberg
    Fabian Caro
    Wibke Stansen
    Manuel Quaresma
    Leticia Orsatti
    Elisabeth Bendstrup
    Respiratory Research, 22
  • [2] Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities
    Glaspole, Ian
    Bonella, Francesco
    Bargagli, Elena
    Glassberg, Marilyn K.
    Caro, Fabian
    Stansen, Wibke
    Quaresma, Manuel
    Orsatti, Leticia
    Bendstrup, Elisabeth
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [3] Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
    Luca Richeldi
    Martin Kolb
    Stéphane Jouneau
    Wim A. Wuyts
    Birgit Schinzel
    Susanne Stowasser
    Manuel Quaresma
    Ganesh Raghu
    BMC Pulmonary Medicine, 20
  • [4] Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
    Richeldi, Luca
    du Bois, Roland M.
    Raghu, Ganesh
    Azuma, Arata
    Brown, Kevin K.
    Costabel, Ulrich
    Cottin, Vincent
    Flaherty, Kevin R.
    Hansell, David M.
    Inoue, Yoshikazu
    Kim, Dong Soon
    Kolb, Martin
    Nicholson, Andrew G.
    Noble, Paul W.
    Selman, Moises
    Taniguchi, Hiroyuki
    Brun, Michele
    Le Maulf, Florence
    Girard, Mannaig
    Stowasser, Susanne
    Schlenker-Herceg, Rozsa
    Disse, Bernd
    Collard, Harold R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (22): : 2071 - 2082
  • [5] Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
    Richeldi, Luca
    Kolb, Martin
    Jouneau, Stephane
    Wuyts, Wim A.
    Schinzel, Birgit
    Stowasser, Susanne
    Quaresma, Manuel
    Raghu, Ganesh
    BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [6] Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis
    Park, Sojung
    Lee, Jisun
    Kim, Dong Soon
    Song, Jin Woo
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [7] Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis
    Hee-Young Yoon
    Sojung Park
    Dong Soon Kim
    Jin Woo Song
    Respiratory Research, 19
  • [8] Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis
    Yoon, Hee-Young
    Park, Sojung
    Kim, Dong Soon
    Song, Jin Woo
    RESPIRATORY RESEARCH, 2018, 19
  • [9] Nintedanib - efficacy, safety and practical aspects of treatment for patients with idiopathic pulmonary fibrosis
    Martusewicz-Boros, Magdalena
    Gorska, Katarzyna
    ADVANCES IN RESPIRATORY MEDICINE, 2020, 88 (06) : 599 - 607
  • [10] Efficacy and safety of combined use of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis
    Huh, Jin-Young
    Lee, Jae Ha
    Song, Jin Woo
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
12345